Androgens have been shown to upregulate the expression of CXCR4, CXCR2, CXCR8, and, consequently, Bcl2 proteins through NF-κB-regulated transcription, increasing the metastatic capacity of prostate carcinoma cells [40–42]. This evidence concerns the gene BCL2 and prostate carcinoma.